Par Pharmaceutical, Inc. Grabs New Jersey's JHP Pharmaceuticals For $490 Million

Published: Jan 22, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Warburg Pincus LLC is selling JHP Group Holdings LLC to TPG Capital LP-backed Par Pharmaceutical Cos. Inc. for $490 million only one year after acquiring the company, sources said. The deal was announced without terms on Tuesday, Jan. 21. Parsippany, N.J.-based JHP Group is the parent company of JHP Pharmaceuticals, a pharmaceutical company that acquires, develops, manufactures and sells sterile injectable drugs.

Help employers find you! Check out all the jobs and post your resume.

Back to news